Literature DB >> 22552839

Mechanisms of apoptosis by the tumor suppressor Par-4.

Nikhil Hebbar1, Chi Wang, Vivek M Rangnekar.   

Abstract

Par-4 is a pro-apoptotic, tumor suppressor protein that induces apoptosis selectively in cancer cells. Endoplasmic reticulum-stress and higher levels of protein kinase A in tumor cells confer the coveted feature of cancer selective response to extracellular and intracellular Par-4, respectively. Recent studies have shown that systemic Par-4 confers resistance to tumor growth in mice, and that tumor-resistance is transferable by bone-marrow transplantation. Moreover, recombinant Par-4 inhibits the growth of tumors in mice. As systemic Par-4 induces apoptosis via cell surface GRP78, strategies that promote GRP78 trafficking to the cell surface are expected sensitize cancer cells to circulating levels of Par-4. This review illustrates the domains and mechanisms by which Par-4 orchestrates the apoptotic process in both cell culture models and in physiological settings.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22552839      PMCID: PMC3414654          DOI: 10.1002/jcp.24098

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  50 in total

1.  Decreased expression of the pro-apoptotic protein Par-4 in renal cell carcinoma.

Authors:  J Cook; S Krishnan; S Ananth; S F Sells; Y Shi; M M Walther; W M Linehan; V P Sukhatme; M H Weinstein; V M Rangnekar
Journal:  Oncogene       Date:  1999-02-04       Impact factor: 9.867

Review 2.  Free radicals, metals and antioxidants in oxidative stress-induced cancer.

Authors:  M Valko; C J Rhodes; J Moncol; M Izakovic; M Mazur
Journal:  Chem Biol Interact       Date:  2006-01-23       Impact factor: 5.192

3.  Binding and phosphorylation of par-4 by akt is essential for cancer cell survival.

Authors:  Anindya Goswami; Ravshan Burikhanov; Aurelie de Thonel; Naoya Fujita; Mamta Goswami; Yanming Zhao; John E Eriksson; Takashi Tsuruo; Vivek M Rangnekar
Journal:  Mol Cell       Date:  2005-10-07       Impact factor: 17.970

4.  Phosphorylation of Par-4 by protein kinase A is critical for apoptosis.

Authors:  Sushma Gurumurthy; Anindya Goswami; Krishna Murthi Vasudevan; Vivek M Rangnekar
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

5.  Deregulated expression of prostate apoptosis response gene-4 in less differentiated lymphocytes and inverse expressional patterns of par-4 and bcl-2 in acute lymphocytic leukemia.

Authors:  S Boehrer; K U Chow; E Puccetti; M Ruthardt; S Godzisard; A Krapohl; B Schneider; D Hoelzer; P S Mitrou; V M Rangnekar; E Weidmann
Journal:  Hematol J       Date:  2001

6.  Inactivation of the candidate tumor suppressor par-4 in endometrial cancer.

Authors:  Gema Moreno-Bueno; Pablo J Fernandez-Marcos; Manuel Collado; Mercedes J Tendero; Socorro M Rodriguez-Pinilla; Isabel Garcia-Cao; David Hardisson; Maria T Diaz-Meco; Jorge Moscat; Manuel Serrano; Jose Palacios
Journal:  Cancer Res       Date:  2007-03-01       Impact factor: 12.701

7.  Tumour-suppression activity of the proapoptotic regulator Par4.

Authors:  Isabel García-Cao; Angeles Duran; Manuel Collado; Maria J Carrascosa; Juan Martín-Caballero; Juana M Flores; Maria T Diaz-Meco; Jorge Moscat; Manuel Serrano
Journal:  EMBO Rep       Date:  2005-06       Impact factor: 8.807

Review 8.  NF-kappaB and IKK as therapeutic targets in cancer.

Authors:  H J Kim; N Hawke; A S Baldwin
Journal:  Cell Death Differ       Date:  2006-05       Impact factor: 15.828

Review 9.  GRP78 induction in cancer: therapeutic and prognostic implications.

Authors:  Amy S Lee
Journal:  Cancer Res       Date:  2007-04-15       Impact factor: 12.701

Review 10.  The inhibitors of apoptosis (IAPs) and their emerging role in cancer.

Authors:  E C LaCasse; S Baird; R G Korneluk; A E MacKenzie
Journal:  Oncogene       Date:  1998-12-24       Impact factor: 9.867

View more
  27 in total

1.  c-Src, Insulin-Like Growth Factor I Receptor, G-Protein-Coupled Receptor Kinases and Focal Adhesion Kinase are Enriched Into Prostate Cancer Cell Exosomes.

Authors:  Rachel M DeRita; Brad Zerlanko; Amrita Singh; Huimin Lu; Renato V Iozzo; Jeffrey L Benovic; Lucia R Languino
Journal:  J Cell Biochem       Date:  2016-07-12       Impact factor: 4.429

2.  Par-4 overexpression impedes leukemogenesis in the Eµ-TCL1 leukemia model through downregulation of NF-κB signaling.

Authors:  J T Greene; Rajeswaran Mani; Rahul Ramaswamy; Frank Frissora; Max Yano; Kevan Zapolnik; Bonnie Harrington; Ronni Wasmuth; Minh Tran; Xiaokui Mo; Mary McKenna; Vivek M Rangnekar; John C Byrd; Subbarao Bondada; Natarajan Muthusamy
Journal:  Blood Adv       Date:  2019-04-23

3.  Prostate Apoptosis Response-4 (Par-4): A Novel Target in Pyronaridine-Induced Apoptosis in Glioblastoma (GBM) Cells.

Authors:  Jeevan Ghosalkar; Vinay Sonawane; Tejal Pisal; Swati Achrekar; Radha Pujari; Ashish Chugh; Padma Shastry; Kalpana Joshi
Journal:  Cancers (Basel)       Date:  2022-06-29       Impact factor: 6.575

Review 4.  A journey beyond apoptosis: new enigma of controlling metastasis by pro-apoptotic Par-4.

Authors:  Reyaz Ur Rasool; Debasis Nayak; Souneek Chakraborty; Archana Katoch; Mir Mohd Faheem; Hina Amin; Anindya Goswami
Journal:  Clin Exp Metastasis       Date:  2016-08-27       Impact factor: 5.150

5.  Foxo-dependent Par-4 Upregulation Prevents Long-term Survival of Residual Cells Following PI3K-Akt Inhibition.

Authors:  Jeffrey S Damrauer; Stephanie N Phelps; Katie Amuchastegui; Ryan Lupo; Nathaniel W Mabe; Andrea Walens; Benjamin R Kroger; James V Alvarez
Journal:  Mol Cancer Res       Date:  2018-01-12       Impact factor: 5.852

6.  Development of a novel prostate apoptosis response-4 (Par-4) protein entity with an extended duration of action for therapeutic treatment of cancer.

Authors:  Kyungbo Kim; Pereira Araujo; Nikhil Hebbar; Ziyuan Zhou; Xirong Zheng; Fang Zheng; Vivek M Rangnekar; Chang-Guo Zhan
Journal:  Protein Eng Des Sel       Date:  2019-12-13       Impact factor: 1.650

7.  Par-4 secretion: stoichiometry of 3-arylquinoline binding to vimentin.

Authors:  Vitaliy M Sviripa; Ravshan Burikhanov; Josiah M Obiero; Yaxia Yuan; Justin R Nickell; Linda P Dwoskin; Chang-Guo Zhan; Chunming Liu; Oleg V Tsodikov; Vivek M Rangnekar; David S Watt
Journal:  Org Biomol Chem       Date:  2016-01-07       Impact factor: 3.876

8.  Par(-4)oxysm in breast cancer.

Authors:  Tripti Shrestha-Bhattarai; Nikhil Hebbar; Vivek M Rangnekar
Journal:  Cancer Cell       Date:  2013-07-08       Impact factor: 31.743

9.  Parasporin-2 from a New Bacillus thuringiensis 4R2 Strain Induces Caspases Activation and Apoptosis in Human Cancer Cells.

Authors:  Kevin Brasseur; Pascal Auger; Eric Asselin; Sophie Parent; Jean-Charles Côté; Marc Sirois
Journal:  PLoS One       Date:  2015-08-11       Impact factor: 3.240

10.  Plant-derived SAC domain of PAR-4 (Prostate Apoptosis Response 4) exhibits growth inhibitory effects in prostate cancer cells.

Authors:  Shayan Sarkar; Sumeet Jain; Vineeta Rai; Dipak K Sahoo; Sumita Raha; Sujit Suklabaidya; Shantibhusan Senapati; Vivek M Rangnekar; Indu B Maiti; Nrisingha Dey
Journal:  Front Plant Sci       Date:  2015-10-07       Impact factor: 5.753

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.